We first examined the relationships of blood hemoglobin level with three AD pathologies (i.e., cerebral Aβ deposition, tau deposition, and AD-signature neurodegeneration) and white matter hyperintensities (WMHs), which are a measure of cerebrovascular injury. This evidence concerns the gene MAPT and Alzheimer disease.